The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Block Listing Interim Review

8 Mar 2023 17:28

RNS Number : 3552S
Allergy Therapeutics PLC
08 March 2023
 

Allergy Therapeutics plc

Block Listing Interim Review

 

 

Date 8 March 2023

 

Name of applicant:

ALLERGY THERAPEUTICS PLC

Name of scheme:

Allergy Therapeutics plc 2013 Long Term Incentive Plan 

Period of return:

From:

1 August 2022

To:

28 February 2023

Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:

10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017

Balance of unallotted securities under scheme(s) from previous return:

7,118,772 ordinary shares

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

7,118,772 ordinary shares

 

Name of contact:

Karley Cheesman

Telephone number of contact:

+44 (0) 1903 844 700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLREAXDPEAXDEFA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.